Settings
ADHD [NASD]
Alcobra Ltd.
Index- P/E- EPS (ttm)-2.35 Insider Own46.31% Shs Outstand21.17M Perf Week-0.31%
Market Cap135.49M Forward P/E- EPS next Y-1.96 Insider Trans0.00% Shs Float14.85M Perf Month65.37%
Income-31.70M PEG- EPS next Q-0.60 Inst Own18.20% Short Float7.47% Perf Quarter12.68%
Sales- P/S- EPS this Y-420.00% Inst Trans-4.34% Short Ratio3.22 Perf Half Y-64.44%
Book/sh1.90 P/B3.37 EPS next Y21.90% ROA-76.20% Target Price18.17 Perf Year-71.49%
Cash/sh1.39 P/C4.61 EPS next 5Y- ROE-83.50% 52W Range3.12 - 25.44 Perf YTD71.58%
Dividend- P/FCF- EPS past 5Y0.00% ROI- 52W High-74.84% Beta-
Dividend %- Quick Ratio6.30 Sales past 5Y- Gross Margin- 52W Low105.13% ATR0.64
Employees9 Current Ratio6.30 Sales Q/Q- Oper. Margin- RSI (14)67.84 Volatility12.50% 12.51%
OptionableYes Debt/Eq0.00 EPS Q/Q-175.00% Profit Margin- Rel Volume0.41 Prev Close6.53
ShortableYes LT Debt/Eq0.00 EarningsFeb 18 Payout- Avg Volume344.02K Price6.40
Recom2.20 SMA2027.52% SMA5055.22% SMA200-49.96% Volume153,700 Change-1.99%
Nov-18-14Reiterated ROTH Capital Buy $30 → $10
Oct-23-14Downgrade FBR Capital Outperform → Mkt Perform $22 → $4
Oct-07-14Upgrade WBB Securities Hold → Speculative Buy $18 → $9
Oct-07-14Upgrade FBR Capital Mkt Perform → Outperform $23 → $22
Oct-06-14Reiterated ROTH Capital Buy $40 → $30
Aug-27-14Initiated FBR Capital Mkt Perform $23
Jun-26-14Initiated WBB Securities Hold $18
Apr-17-14Initiated Canaccord Genuity Buy $24
Dec-04-13Initiated Stifel Buy $27
Oct-08-13Reiterated Aegis Capital Buy $30 → $40
Jul-08-13Initiated Aegis Capital Buy $30
Jan-19-15 07:31AM  Can the Uptrend Continue for Alcobra (ADHD)? - Tale of the Tape Zacks
Jan-14-15 06:08PM  Nasdaq stocks posting largest percentage increases AP +10.91%
02:16PM  UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Alcobra Ltd. and a Lead Plaintiff Deadline of January 20, 2015 GlobeNewswire
09:00AM  Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option GlobeNewswire
Jan-12-15 03:05PM  Rosen Law Firm Reminds Alcobra Ltd. Investors of Important January 19, 2015 Deadline in Class Action - ADHD GlobeNewswire +5.86%
12:32PM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Alcobra, Ltd. Business Wire
Jan-09-15 01:11PM  UPDATE UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 20, 2015 -- ADHD Business Wire +24.47%
09:06AM  Alcobra Ltd. Prices Public Offering of Ordinary Shares GlobeNewswire
Jan-08-15 04:19PM  Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares GlobeNewswire +6.25%
Jan-07-15 10:32AM  INVESTOR ALERT: Class Action Lawsuit Against Alcobra, Ltd. Announced by Law Offices of Howard G. Smith Business Wire
Jan-02-15 12:52PM  ADHD SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 19, 2015 -- ADHD PR Newswire
Dec-30-14 08:00PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra Ltd. To Contact Brower Piven Before The January 19, 2015 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Dec-29-14 05:07PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Alcobra, Ltd. Marketwired
04:23PM  ADHD SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 19, 2015 -- ADHD Marketwired
Dec-17-14 12:26PM  Alcobra Ltd. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire +7.30%
12:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Alcobra Ltd. (ADHD) to Contact the Firm GlobeNewswire
Dec-16-14 06:16PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Alcobra Ltd. to Contact Brower Piven Before the January 19, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- ADHD GlobeNewswire +8.21%
04:52PM  ADHD SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 19, 2015 -- ADHD GlobeNewswire
03:18PM  Law Offices Bernard M. Gross, P.C. Filed a Class Action Lawsuit Against Alcobra Ltd. and Its Officers -- ADHD GlobeNewswire
Dec-12-14 04:06PM  EQUITY ALERT: Rosen Law Firm Reminds Alcobra Ltd. Investors of Important Deadline in Class Action -- ADHD GlobeNewswire
Dec-08-14 09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
Dec-02-14 12:21PM  ADHD SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Alcobra Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 19, 2015 -- ADHD GlobeNewswire -5.07%
Dec-01-14 04:50PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra Ltd. To Contact Brower Piven Before The January 19, 2015 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Nov-26-14 04:44PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alcobra Ltd. (ADHD) To Contact The Firm PR Newswire
Nov-25-14 03:11PM  Rosen Law Firm Announces Filing of Securities Class Action Against Alcobra Ltd. to Recover Investor Losses - ADHD GlobeNewswire
Nov-24-14 09:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alcobra Ltd - ADHD PR Newswire
05:46PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Alcobra Ltd. to Contact Brower Piven Before the January 19, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- ADHD GlobeNewswire
08:00AM  Alcobra Ltd. to Present at Investor Conferences in December GlobeNewswire
Nov-21-14 06:28PM  Robbins Arroyo LLP: Alcobra Ltd. (ADHD) Misled Shareholders According to a Recently Filed Class Action GlobeNewswire
10:32AM  SHAREHOLDER ALERT: Investigation on Behalf of Alcobra, Ltd. Investors Announced by Law Offices of Howard G. Smith Business Wire
Nov-20-14 05:48PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Alcobra Ltd. (ADHD) to Contact the Firm Marketwired
Nov-19-14 05:07PM  SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP Business Wire
Nov-17-14 05:19PM  Aegis Capital Downgrades Alcobra Following Q3 Results Benzinga -5.74%
07:00AM  Alcobra Announces Third Quarter Financial Results and Provides Corporate Update GlobeNewswire
Nov-14-14 02:10PM  Bruker Downgraded to Sell on Disappointing Q3 Outcome Zacks
08:13AM  Flamel Technologies (FLML) in Focus: Stock Rises 11% Zacks
Nov-11-14 05:44AM  Regulus Slumps: RGLS Falls 5.3% in Session Zacks
Nov-06-14 08:00AM  Alcobra Ltd. to Release Third Quarter 2014 Financial Results and Host Corporate Update Conference Call and Webcast on Monday, November 17 GlobeNewswire +6.32%
Nov-03-14 08:00AM  Alcobra Ltd. to Present at Investor Conferences in November GlobeNewswire
Oct-31-14 11:53AM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by the Board of Directors of Alcobra Ltd. Business Wire
Oct-30-14 07:24AM  Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% Zacks
Oct-28-14 10:30AM  INVESTOR ALERT: Investigation on Behalf of Alcobra Ltd. Shareholders Announced by Glancy Binkow & Goldberg LLP Business Wire
08:28AM  Zacks Rank #1 Additions for Tuesday Zacks
Oct-27-14 05:19PM  Block & Leviton LLP Investigates Alcobra Ltd, Its Officers and Directors for Possible Violations of the Federal Securities Laws PR Newswire
Oct-23-14 02:43PM  Alcobra Pharma downgraded by FBR Capital Briefing.com -26.06%
01:27PM  Midday Losers From October 23: Yelp, Alcobra, Ultratech Benzinga
09:26AM  Alcobra Applies Revisionist History to ADHD Drug Study Analysis at TheStreet
07:25AM  Alcobra Announces Presentation of New Data From Phase III Adult ADHD Study at AACAP Annual Meeting GlobeNewswire
Oct-17-14 09:41AM  5 Stocks Under $10 Set to Soar at TheStreet
Oct-08-14 02:30PM  Alcobra Reveals ADHD Top-line Phase III Data, Shares Down Zacks
08:08AM  Strength Seen in Alcobra (ADHD): Stock Rises 6.4% Zacks
Oct-07-14 08:35AM  Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More at 24/7 Wall St. +6.37%
Oct-06-14 03:10PM  Why Alcobra (ADHD) Stock Hit a One-Year Low Today at TheStreet -56.63%
01:06PM  Alcobra ADHD drug meets goals, after data excluded; stock tanks Reuters
11:50AM  Alcobra Loses Focus in ADHD Trial for FDA Approval at 24/7 Wall St.
10:08AM  Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis at TheStreet
09:44AM  Stocks to Watch: H-P, Becton Dickinson, CareFusion at The Wall Street Journal
08:46AM  US STOCKS-Small biotech stocks plummet in premarket Reuters
06:41AM  Alcobra (ADHD) Crumbles: Stock Falls by 7.4% Zacks
06:00AM  Alcobra Announces Topline Results From Phase III Study of MDX in Adult ADHD GlobeNewswire
Oct-01-14 06:20PM  Nasdaq stocks posting largest percentage decreases AP -14.18%
Sep-24-14 09:04AM  Why Alcobra Investors Are So Nervous About a Coming Drug Study at TheStreet
Sep-23-14 05:00PM  Assurant (AIZ) Upgraded to Buy on New CEO, Acquisition Zacks
Sep-19-14 04:21PM  Alcobra Announces Completion of All Patient Visits in Phase III Clinical Trial of MDX in Adult ADHD GlobeNewswire
Sep-18-14 08:10AM  Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher Zacks
Sep-05-14 08:00AM  Alcobra Ltd. to Present at the Aegis Healthcare & Technology Conference GlobeNewswire
06:41AM  Weakness Seen in Alcobra (ADHD): Stock Falls 6.6% Zacks
Sep-02-14 08:00AM  Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Adolescents With ADHD GlobeNewswire
Aug-27-14 09:58AM  Why Alcobra (ADHD) Stock Is Declining Today at TheStreet
Aug-20-14 05:21PM  Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX Zacks
Aug-19-14 08:00AM  Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Fragile X Syndrome GlobeNewswire
Aug-11-14 08:30AM  Alcobra Ltd Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q2 2014 Alcobra Ltd Earnings Release - Time Not Supplied CCBN
07:00AM  Alcobra Announces Second Quarter Financial Results and Provides Corporate Update GlobeNewswire
Aug-08-14 08:41AM  Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects of MDX GlobeNewswire
Aug-06-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the Canaccord Genuity 34th Annual Growth Conference GlobeNewswire +6.92%
Aug-01-14 08:00AM  Alcobra Ltd. to Release Second Quarter 2014 Results and Host Investor Conference Call and Webcast on Monday, August 11 GlobeNewswire
Jul-17-14 08:12AM  Alcobra Discusses New Market Research and Updates on Recent Corporate Events at Investor Forum in New York City GlobeNewswire
Jul-14-14 08:00AM  Alcobra Completes Patient Recruitment in Phase III Clinical Trial of MDX in Adult ADHD GlobeNewswire
Jul-07-14 08:00AM  Alcobra to Host Investor Forum and Webcast on July 15 in New York City GlobeNewswire
Jul-03-14 09:04AM  5 Stocks Spiking on Unusual Volume at TheStreet
08:16AM  Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session Zacks
Jul-02-14 07:19AM  Alcobra shares should be bought ahead of data, says Stifel theflyonthewall.com +5.85%
Jun-24-14 06:56AM  Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% Zacks
Jun-17-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference GlobeNewswire
Jun-12-14 02:25AM  Alcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% Zacks
Jun-09-14 08:00AM  Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention GlobeNewswire
May-27-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference GlobeNewswire
May-23-14 08:00AM  Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders GlobeNewswire
May-15-14 01:33PM  Alcobra's (ADHD) CEO Yaron Daniely on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
07:30AM  Alcobra Announces First Quarter Financial Results and Corporate Update GlobeNewswire
May-12-14 08:22AM  Alcobra presents improved data for Metadoxine at theflyonthewall.com
08:00AM  Alcobra Ltd. Presents Evidence of Novel Mechanism of Action for Metadoxine Extended Release (MDX) in Cognitive Disorders at the Society of Biological Psychiatry Annual Meeting GlobeNewswire
May-08-14 12:22PM  Alcobra gets FDA approval for Phase IIb trial of MDX at theflyonthewall.com
12:20PM  Alcobra Announces FDA Clearance of Protocol for Phase IIb Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome GlobeNewswire
08:00AM  Alcobra Ltd. to Provide Corporate Overview at Oppenheimer and BioMed Conferences GlobeNewswire
07:24AM  Society of Biological Psychiatry to hold scientific meeting at theflyonthewall.com
May-07-14 04:05PM  Alcobra Ltd. to Release First Quarter 2014 Results and Host Investor Conference Call on Thursday, May 15, 2014 GlobeNewswire
May-06-14 11:52AM  Alcobra Ltd. Poised To Gain Some Attention In ADHD Market at Seeking Alpha
May-05-14 08:00AM  Alcobra Ltd. Presents Positive Results From Phase IIb Study of Metadoxine Extended Release (MDX) in Adults With Predominantly Inattentive ADHD at APA Annual Meeting GlobeNewswire
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognitive dysfunctions, including Fragile X. The company has initiated a Phase III clinical trial in the United States for the use of MDX to treat ADHD in adults. Alcobra Ltd. was founded in 2008 and is headquartered in Tel Aviv, Israel.